POSTER SESSION II
Monday, February 28, 2011 — 1:00 PM - 4:30 PM
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
GASTROINTESTINAL PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
79
Pauci-Eosinophilic Esophagitis: An Under-Recognized Variant of Eosinophilic Esophagitis.
(645)
S Jakate - Rush University Medical Center, Chicago, IL
Surface Hyaline Keratosis Is a Highly Significant Marker of Reflux vs. Eosinophilic Esophagitis: A Multivariate Analysis Study.
(684)
AD Polydorides, M Chehade, M Raoufi, N Harpaz - Mt Sinai School of Medicine, New York, NY
SIRT1 Is a Useful Marker for Epithelial Dysplasia and Neoplasia in Barrett's Esophagus.
(722)
XI Wang, S Zhang, V Tanya, J Thomas - Louisiana State University Health Science Center, Shreveport
Evaluation of Esophageal Biopsies for Squamous Intraepithelial Neoplasia: Differences between Japan and the West.
(701)
M Shimizu, J Aida, IS Brown, JK Greenson, A Jouret-Mourin, H Kawachi, JK Lennerz, K Nagata, K Takubo, M Vieth, GY Lauwers - Saitama Medical University, International Medical Center, Hidaka, Japan; Tokyo Metropolitan Institute of Gerontology, Itabashi-ku, Japan; Sullivan Nicolaides Pathology, Brisbane, QLD, Australia; University of Michigan, Ann Arbor; Universite Catholique de Louvain, Brussels, Belgium; Tokyo Medical and Dental University, Bunkyo-ku, Japan; Massachusetts General Hospital, Boston; Klinikum Bayreuth, Bayreuth, Germany
Does Histology of Gastroesophageal Junction (GEJ) Biopsies Predict Future Development of Barrett's Esophagus (BE).
(691)
TA Rege, JR Goldblum, G Falk, F Kuo, RD Odze - Brigham & Women's Hospital, Boston, MA; Cleveland Clinic, OH; University of Pennsylvania Health System, Philadelphia
Role of Inflammation in Barrett's Esophagus-Related Cancer Development.
(669)
M McIntire, CA Sanchez, DS Cowan, B Reid, PY Fong, PL Blount, RD Odze - Brigham and Women's Hospital, Boston; Fred Hutchinson Cancer Center, Seattle
Sox-9 Immunohistochemistry Demonstrates Abnormal Distribution of Gastrointestinal Stem Cells in Specialized and Non-Specialized Barrett's Mucosa.
(625)
M Goodarzi, R Kanhere, L Corley, A Correa, J Ajani, S Swisher, W Hofstetter, A Rashid, D Maru - The University of Texas M.D.Anderson Cancer Center, Houston; Caris Research Institute, Caris Life Sciences, Newton
An Oncofetal Protein IMP3, a New Molecular Marker for the Detection of Dysplasia and Carcinoma of the Gallbladder.
(706)
T Stockl, Z Jiang - UMass Memorial Medical Center, Worcester, MA
Mitoses, Genomic Instability and Neoplastic Progression in Barrett's Esophagus.
(610)
D Coco, A Srivastava, C Sanchez, PY Fong, X Li, D Cowan, C Maley, P Blount, B Reid, RD Odze - Brigham and Women's Hospital, Boston; Dartmouth Hitchcock Medical Center, Lebanon; Fred Hutchinson Cancer Research Center, Seattle; UCSF, San Francisco, CA
Methylation Status of E-Cadherin, p14, DAB-Kinase and THBS1 in Non-Specialized Columnar Metaplasia of the Esophagus.
(636)
R Herrera-Goepfert, JL Mosqueda-Vargas, LA Herrera, LF Onate-Ocana, C Castro-Hernandez, M Camorlinga-Ponce - Instituto Nacional de Cancerologia, Mexico, DF, Mexico; Instituto de Investigaciones Biomedicas,UNAM, Mexico, DF, Mexico; Unidad de Investigacion Medica de Enfermedades Infecciosas, Centro Medico Nacional Siglo XXI, Mexico, DF, Mexico
Barrett's Esophagus Associated Stem Cells.
(634)
S Heaton, P Sochacki, N Khoury, E Levi - John D. Dingell VA Medical Center, Detroit, MI; Wayne State University School of Medicine, Detroit
Dietary Zinc Inhibits N-Nitrosomethylbenzylamine-Induced Esophageal Carcinogenesis in Wild-Type and Tumor Suppressor-Deficient Mouse Strains.
(661)
J Liu, J Sun, X Pan, D Quimby, N Zanesi, T Druck, GP Pfeifer, CM Croce, LY Fong3, K Huebner - Ohio State University, Columbus; The City of Hope National Medical Center, Duarte, CA; Jefferson Medical College, Philadelphia, PA
Staging of Gastroesophageal Junction Adenocarcinoma with 7th Edition AJCC Staging Manual: Accuracy of Tumor Grade Assessment in Biopsy Specimens.
(615)
JL Dikken, DG Coit, DS Klimstra, NP Rizk, N van Grieken, D Ilson, LH Tang - Memorial Sloan-Kettering Cancer Center, New York, NY; Leiden University Medical Center, Netherlands; Free University, Amsterdam, Netherlands
MGMT (O6-MethylguanineDNA Methyltransferase) Is Inactivated in a Significant Subset of Distal Esophageal Adenocarcinomas: Implications for Neoadjuvant Chemoradiation Therapy.
(660)
M Lisovsky, M Mino-Kenudson, J Lefferts, E Courville, B Zaki, LN Calvo, TS Hong, GJ Tsongalis, GY Lauwers, A Srivastava - Dartmouth Hitchcock Medical Center, Lebanon, NH; Massachusetts General Hospital, Boston
Cyclin E Amplification and Overexpression in Esophageal Carcinoma and Dysplasia by SNP Microarray and Immunohistochemisty Studies.
(724)
J Ye, S Bandla, Y Xia, D Tan, J Peters, T Godfrey, T Godfrey, Z Zhou - University of Rochester, NY, United Kingdom; University of Rochester, NY; MD Anderson Cancer Center, Houston, TX
Superficial (pT1b) Basaloid Squamous Cell Carcinoma of the Esophagus: Its Clinicopathologic Findings.
(671)
K Nagata, M Shimizu - Saitama Medical University, International Medical Center, Hidaka, Japan
Prevalence and Prognostic Significance of HER2 Amplification in Adenocarcinoma of the Esophagus and GE Junction.
(687)
O Radu, K Nason, J Davison - UPMC, Pittsburgh, PA
button next to any title to add to Itinerary Planner...
Add
